TheraCann announces termination of agreement with Maple Leaf Green World

Saturday, June 3, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CALGARY, June 2, 2017 /CNW/ - TheraCann International Benchmark Corporation, a leading full service

international cannabis consultancy ("TheraCann" or "the Company"), has announced today that as of May 29th, 2017 the Company terminated the consulting agreement with Maple Leaf Green World Inc. (TSXV: MGW) due
to a material breach of contract. Maple Leaf was served with notice of breach on May 19th, 2017 and had until May 25th to remedy the situation.  

TheraCann's terminated agreement included a full review of Maple Leaf's Access to Cannabis for Medical Purposes (ACMPR) Application, site suitability audits, cultivation strategies, and project security overview. The company has stated that Maple Leaf Green World Inc. has not operated in good faith and has failed to fulfill their obligations as pursuant to the agreement including but not limited to; utilizing TheraCann's reputation to raise capital without fulfilling any commitment to, or intention of, employing TheraCann's services, misleading Company representatives as to material facts relating to their ACMPR application, and failure to remunerate TheraCann for agreed services rendered.

TheraCann will be pursuing any and all remedies to negotiate this material contract breach by Maple Leaf Green World and will continue until the Company deems a suitable resolution is achieved. 

###

About TheraCann International Benchmark Corporation

TheraCann International Benchmark Corporation offers a one-stop, full-service solution for the International cannabis marketplace. From regulatory applications, planning, facility design, cultivation, marketing and communications, TheraCann provides cannabis-related businesses with solutions to fit their regulatory requirements. More information about TheraCann is available at www.theracanncorp.com.

 

SOURCE TheraCann International



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook